Search the web
Welcome, Guest
[Sign Out, My Account]

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
PETX > SEC Filings for PETX > Form 8-K on 23-Jun-2014All Recent SEC Filings

Show all filings for ARATANA THERAPEUTICS, INC.



Change in Directors or Principal Officers

Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On June 23, 2014, the Board of Directors (the "Board") of Aratana Therapeutics, Inc. (the "Company") elected Robert P. Roche, Jr. as a Class III director of the Company. Mr. Roche has been appointed to serve on the Nominating and Corporate Governance Committee of the Board (the "Nominating Committee"), replacing Wendy L. Yarno on the Nominating Committee.

Mr. Roche will participate in the Company's compensation program for non-employee directors, as amended, including an annual retainer of $35,000, an additional annual retainer of $3,500 for his service on the Nominating Committee and an initial award of an option to purchase 20,000 shares of the Company's common stock (the "Initial Award"). The Initial Award has an exercise price per share equal to $15.80, the fair market value of a share of the Company's common stock on the date of grant, and will vest and become exercisable in equal installments on each of the first four anniversaries of the date of grant, subject to Mr. Roche's continued service on the Board through each such vesting date, subject to full acceleration in the event of a change in control of the Company. Mr. Roche has also entered into the Company's standard indemnification agreement for directors.

  Add PETX to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for PETX - All Recent SEC Filings
Copyright © 2015 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.